Revisão Revisado por pares

Phosphatidylinositol 3-Kinase, Growth Disorders, and Cancer

2018; Massachusetts Medical Society; Volume: 379; Issue: 21 Linguagem: Inglês

10.1056/nejmra1704560

ISSN

1533-4406

Autores

Marcus D. Goncalves, Benjamin D. Hopkins, Lewis C. Cantley,

Tópico(s)

Toxin Mechanisms and Immunotoxins

Resumo

Phosphatidylinositol 3-kinase (PI3K) is involved in multiple cell processes, including insulin signaling, cell growth, immunity, and brain development. It is activated in a wide variety of cancers and is being targeted as a treatment, with notable success in lymphoma.

Referência(s)